Since FHL2 also tethers muscle-specific metabolic enzymes (i.e., adenylate kinase, phosphofructokinase, and muscle-type creatinine kinase [77]), the DCM-causing FHL2 mutation would impair the recruitment of these metabolic enzymes to titin. The gene discussed is TTN; the disease is familial dilated cardiomyopathy.